| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |